Orchard Therapeutics plc Analytics - Traffic, Statistics and Competitor Tracking


Orchard Therapeutics plc Website Screenshot

http://www.orchard-tx.com

Orchard Therapeutics plc Company Intro

Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-201 for mucopolysaccharidosis type MPS-IIIA and OTL-202 for mucopolysaccharidosis type IIIB. Orchard Therapeutics plc entered into a manufacturing and technology development agreement with MolMed S.p.A. to develop, manufacture and supply certain viral vectors and conduct cell processing activities for certain Orchard development and commercial programs. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is based in London, the United Kingdom.

Industry

Healthcare

Orchard Therapeutics plc Headquaters

108 Cannon Street
London,EC4N 6EU
United Kingdom


Orchard Therapeutics plc Share price

14 May 2021 02:19 GMT

$5.40

0.12 (2.27 %)


Orchard Therapeutics plc Market cap

$697.46 M


WMC RANKING

2021

Orchard Therapeutics plc # 234

Biotechnology

Latest Orchard Therapeutics plc News



WMC Market Score


WMC Market to Revenue Score


Orchard Therapeutics plc Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Orchard Therapeutics plc USD $2,513 $174,581 $-163,422 $6,975M 234
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $540,220B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $550,560B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $380,130B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $181,110B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Orchard Therapeutics plc Social Followers vs Top 4 Industry Competitors



Orchard Therapeutics plc Post vs Top 4 Industry Competitors




Orchard Therapeutics plc Digital Footprint By Size vs Top 4 Industry Competitors



Orchard Therapeutics plc Digital Footprint By Change Rate vs Top 4 Industry Competitors



Orchard Therapeutics plc WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Orchard Therapeutics plc 0.03 32.24 1.00 0 0 0 12.93
Regeneron Pharmaceuticals, Inc. 100 23.93 2.32 100 0 0 48.53
Vertex Pharmaceuticals Incorporated 67.14 34.98 0.73 86 0 0 46.73
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.93 0.05 2 0 0 2.85

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries